Evidence map›Paper›PMID 39934796›Full record

ReviewMalaria journal2025

Half-decade of scaling up malaria control: malaria trends and impact of interventions from 2018 to 2023 in Rwanda.

Arlette Umugwaneza, Mathijs Mutsaers, Jean Claude Semuto Ngabonziza, Johanna Helena Kattenberg, Aline Uwimana, Ayman Ahmed, Eric Remera, Theogene Kubahoniyesu, Christian Nsanzabaganwa, Hassan Mugabo and 6 more

Abstract readReview
In one paragraph

Review in Malaria journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Genomic Surveillance ofPathogens (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Review
  13. Article
  14. Genetic polymorphism ofFrontiers in parasitology · 2025
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Arlette UmugwanezaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda. arletteumu@gmail.com.
Mathijs MutsaersBiomedical Sciences Department, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Jean Claude Semuto NgabonzizaResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Johanna Helena KattenbergBiomedical Sciences Department, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.
Aline UwimanaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Ayman AhmedResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Eric RemeraResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Theogene KubahoniyesuResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Christian NsanzabaganwaResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Hassan MugaboResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Gilbert RukundoResearch Innovation Data Science Division, Rwanda Biomedical Centre, Ministry of Health Kigali, Kigali, Rwanda.
Michee KaberaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Aimable MbituyumuremyiMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Emmanuel HakizimanaMalaria and Other Parasitic Diseases Division, Rwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Claude Mambo MuvunyiRwanda Biomedical Centre, Ministry of Health, Kigali, Rwanda.
Anna Rosanas-UrgellBiomedical Sciences Department, Institute of Tropical Medicine Antwerp, Antwerp, Belgium. arosanas@itg.be.

Funding

Belgian Directorate-General for Development Cooperation FA5
6 · The paper itself

Abstract

backgroundRwanda has made significant strides in malaria control. This study reviews malaria epidemiology and control strategies in Rwanda from 2018 to 2023, documenting their impact, persistent gaps and emerging challenges.

methodsData on Rwanda's malaria context from 2018 to 2023 were obtained through a literature review of peer-reviewed articles and grey literature, including annual reports from the malaria programmes, partners, the African Union, and the World Health Organization (WHO). Specific keywords used for the search included "malaria", "Rwanda", "case management", "control", "treatment", and "prevention". Moreover, epidemiological data for this period was extracted from the Health Management Information System (HMIS). Data analysis was done using R & R-Studio, ANOVA to assess the statistical significance (P < 0.05) of observed trends and T-test to compare the focal and blanket IRS techniques. RESULTS/DISCUSSION: Between 2018 and 2023, all malaria indicators showed improvement. Malaria incidence dropped from 345 to 40 cases per 1000 persons (P = 0.00292), the severe malaria rate decreased from 112 to 10/100,000 persons (P = 0.018), and the mortality rate fell from 2.72 to 0.258 deaths /100,000 persons (P = 0.00617). Among children under 5 years of age, incidence decreased significantly from 331 to 52/1,000 persons (P = 0.00123), the severe malaria rate dropped from 214 to 29/100,000 persons (P = 0.00399), and mortality declined from 5 to 0.453/100,000 persons (P = 0.00504). Over the same period, key malaria interventions expanded. The proportion of cases treated by CHWs increased significantly, improving access to early diagnosis and treatment (from 13 to 59%), and the new generations of ITNs (PBO and dual-active ingredient nets) were deployed in 9 districts. Since 2019, a blanket spraying technique has been adopted in 12 IRS districts replacing the focal spraying technique contributing to the significant decrease of malaria incidence from 2019 to 2023 (P = 0.0025). However, new challenges have emerged, including the rise of the K13 R561H mutation associated with artemisinin resistance, the spread of insecticide resistance, and limited intervention coverage due to resource constraints.

conclusionTo sustain the progress achieved, it is essential to intensify malaria control efforts, foster compliance with intervention strategies, enhance surveillance systems for timely and effective responses, and secure long-term funding to sustain these measures.

Indexed as

Communicable Disease ControlMalariaMosquito ControlChild, PreschoolHumansIncidenceRwandaChallengesEpidemiology and malaria controlInterventionsMalariaRwandaTrends

Identifiers

PMID39934796
PMCPMC11817622

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.